French Aerospace & Defense Stock News

ENXTPA:SU
ENXTPA:SUElectrical

Assessing Schneider Electric (ENXTPA:SU) Valuation After EcoStruxure Foxboro SDA Automation Launch

Schneider Electric (ENXTPA:SU) has introduced EcoStruxure Foxboro Software Defined Automation, an open, software-defined distributed control system designed to tackle aging infrastructure, high operating costs, and modernization needs in hybrid and process industries. See our latest analysis for Schneider Electric. The EcoStruxure Foxboro SDA launch lands at a time when Schneider Electric’s 1 month share price return of 13.65% and 90 day share price return of 17.81% suggest firming momentum...
ENXTPA:EL
ENXTPA:ELMedical Equipment

Has The Recent Share Price Slide Opened An Opportunity In EssilorLuxottica (ENXTPA:EL)?

Wondering if EssilorLuxottica Société anonyme is fairly priced at its current level, or if the market is missing something about its long term potential. The share price closed at €238.20, with returns of 7.8% decline over the past week, 11.1% decline over the past month, and 10.3% decline year to date, while the 1 year return is 16.8% decline, compared with gains of 52.5% over 3 years and 90.7% over 5 years. These mixed return figures suggest that sentiment around the stock has shifted over...
ENXTPA:SAN
ENXTPA:SANPharmaceuticals

Is Sanofi (ENXTPA:SAN) Pricing Reflect Its DCF Upside After Recent Share Price Weakness

If you are wondering whether Sanofi shares are offering fair value at around €79.58, you are not alone. This article is built to help you weigh what the current price might be saying. Over the past week the stock is up 2.5%, while the 1 year return sits at a 20.2% decline and the year to date return is a 3.3% decline, with a relatively flat 3 year return of 0.2% and a 5 year return of 27.9%. Recent headlines around Sanofi have focused on the broader healthcare and pharmaceuticals space,...
ENXTPA:ABVX
ENXTPA:ABVXBiotechs

Abivax ECCO Data Sharpen Obefazimod’s IBD Opportunity And Investor Focus

Abivax (ENXTPA:ABVX) presented new preclinical and clinical data for obefazimod at the ECCO Congress. The data highlighted anti fibrotic activity in Crohn's disease and rapid symptomatic relief in inflammatory bowel disease. Large Phase 3 trials were reported to show a strong safety profile and further validation of obefazimod's miR 124 targeting mechanism. Abivax focuses on inflammatory and autoimmune diseases, with obefazimod positioned as its lead asset in inflammatory bowel disease. For...
ENXTPA:AI
ENXTPA:AIChemicals

A Look At Air Liquide (ENXTPA:AI) Valuation After Higher Net Income And Dividend Proposal

L'Air Liquide (ENXTPA:AI) drew attention after reporting full year 2025 results, with net income of €3,517.9m on sales of €26,940.2m, alongside a proposed 12.1% higher dividend of €3.70. See our latest analysis for L'Air Liquide. The proposed 12.1% dividend increase and solid full year 2025 net income appear to have fed into recent optimism, with a 1 month share price return of 11.68% at €175.56 and a 5 year total shareholder return of 86.58%. This suggests that momentum has been building...
ENXTPA:TKO
ENXTPA:TKOCapital Markets

A Look At Tikehau Capital’s Valuation As Full Year 2025 Results Spark Fresh Investor Interest

Tikehau Capital (ENXTPA:TKO) has drawn fresh attention after reporting full year 2025 earnings, with net income of €136.4 million, a proposed €0.80 dividend per share, completed buybacks, and upcoming board changes. See our latest analysis for Tikehau Capital. The strong 1 day share price return of 6.88% to €17.10, alongside a 15.54% 3 month share price return, contrasts with a 1 year total shareholder return of 18.11% decline. This suggests recent momentum has not yet reversed longer term...
ENXTPA:FDJU
ENXTPA:FDJUHospitality

Assessing FDJ United’s Valuation After Earnings, Dividend Hike And 2026 Guidance Shift

Why FDJ United’s latest moves matter for shareholders FDJ United (ENXTPA:FDJU) is back in focus after a packed update, combining full year 2025 results, a proposed dividend increase, fresh 2026 guidance and senior leadership changes on the executive committee. For you as an investor, this mix of operational data, payout policy and management reshuffle helps frame how the business is being run and how shareholder returns are being approached over the coming year. See our latest analysis for...
ENXTPA:BN
ENXTPA:BNFood

Assessing Danone (ENXTPA:BN) Valuation After Recent Share Performance And Mixed Growth Expectations

Without a clear single news catalyst, Danone (ENXTPA:BN) tends to draw attention from investors through its recent share performance, dividend profile, and how its current valuation compares with its underlying fundamentals. See our latest analysis for Danone. At a share price of €73.6, Danone has recently seen a 7.82% 1 month share price return, while its year to date share price return is a 3.21% decline. The 1 year total shareholder return of 10.57% and 3 year total shareholder return of...
ENXTPA:KER
ENXTPA:KERLuxury

Kering (ENXTPA:KER) Valuation Check As Weak 2025 Results Pressure Earnings And Dividend

Kering (ENXTPA:KER) is back in focus after reporting full year 2025 results that showed sales of €14,675m and net income of €72m, sharply below the prior year’s figures. See our latest analysis for Kering. The weak 2025 earnings, the proposed lower ordinary dividend of €3.00 per share and the leadership change at Bottega Veneta have come against a backdrop of a 6.14% 90 day share price decline and a 44.92% 3 year total shareholder return loss. This signals pressure rather than momentum,...
ENXTPA:DBV
ENXTPA:DBVBiotechs

A Look At DBV Technologies (ENXTPA:DBV) Valuation As New VIASKIN Peanut Data Heads To AAAAI 2026

DBV Technologies (ENXTPA:DBV) is back in focus as it prepares to share fresh VITESSE Phase 3 data on its VIASKIN Peanut Patch at the 2026 AAAAI Annual Meeting, spotlighting peanut allergy treatment in young children. See our latest analysis for DBV Technologies. Those upcoming VITESSE Phase 3 readouts and recent conference appearances come after a sharp shift in sentiment, with the share price at €3.56, a 90 day share price return of 48.95% and a 1 year total shareholder return above 300%,...
ENXTPA:NEX
ENXTPA:NEXElectrical

Is It Too Late To Consider Nexans (ENXTPA:NEX) After Its Strong Multi Year Run?

If you are wondering whether Nexans is still reasonably priced after its recent run, or if the value story has started to cool, this article is for you. The share price closed at €126.60, with a 9.8% decline over the past week, a 2.2% gain over the last 30 days, and returns of 21.4% over 1 year, 47.9% over 3 years, and 123.2% over 5 years. These moves have put valuation back in focus, especially for investors comparing the recent short term pullback with the stronger multi year returns. With...
ENXTPA:SAN
ENXTPA:SANPharmaceuticals

Sanofi (ENXTPA:SAN) One Off €3.4b Charge Tests Bullish Earnings Narratives

Sanofi (ENXTPA:SAN) has wrapped up FY 2025 with fourth quarter revenue of €12.2b and a basic EPS loss of €0.67, alongside trailing 12 month revenue of €46.7b and EPS of €4.05 that still reflect the impact of a large one off €3.4b charge. Over recent periods, revenue has moved between €10.6b and €14.2b a quarter, while basic EPS has ranged from €1.01 to €2.32 in the first three quarters of 2025 before this latest loss. This sets a mixed backdrop for the trailing 10.6% net margin versus 12.4% a...
ENXTPA:VRLA
ENXTPA:VRLAPackaging

Verallia Weighs Site Closures As European Demand And Shares Weaken

Verallia Société Anonyme is reviewing its European operations, including potential site closures and job cuts, as part of its sustainability and investment plans. The review focuses on facilities in Germany, France, and the UK, where the company is responding to weaker demand for glass packaging. These possible changes could affect employees and production capacity across key European markets. For investors watching ENXTPA:VRLA, this operational review comes after a period of weaker share...
ENXTPA:GTT
ENXTPA:GTTOil and Gas

European Dividend Stocks To Watch In February 2026

As European markets navigate volatility with the STOXX Europe 600 Index reaching new highs but ending largely unchanged, investors are closely monitoring the impact of AI disruption concerns and robust U.S. job data on their portfolios. In this climate, dividend stocks can offer a measure of stability and income, making them an attractive option for those seeking to balance growth potential with consistent returns.
ENXTPA:HO
ENXTPA:HOAerospace & Defense

3 European Stocks Estimated To Be Trading Below Intrinsic Value

As European markets navigate volatility amid global concerns about AI disruption and economic data surprises, the STOXX Europe 600 Index recently achieved a new high before settling with a modest gain. In such an environment, identifying stocks that are trading below their intrinsic value can offer potential opportunities for investors seeking to capitalize on market inefficiencies.
ENXTPA:DG
ENXTPA:DGConstruction

Is Vinci (ENXTPA:DG) Still Attractive After Strong Five Year Share Price Performance?

If you are wondering whether Vinci's current share price still offers value, this article will walk through what the numbers are really saying about the stock. Vinci shares last closed at €137.75, with returns of 3.1% over 7 days, 18.6% over 30 days, 13.7% year to date, 32.2% over 1 year, 42.1% over 3 years, and 88.0% over 5 years, which may influence how you think about the risk and reward trade off today. Recent price moves sit against a backdrop of ongoing interest in large infrastructure...
ENXTPA:MC
ENXTPA:MCLuxury

Is It Time To Reassess LVMH (ENXTPA:MC) After A 20.9% One Year Share Price Decline

If you are wondering whether LVMH Moët Hennessy - Louis Vuitton Société Européenne is attractively priced today, it helps to step back from the brand power and look closely at what the current share price actually implies. The stock last closed at €533.90, with a 1.7% gain over the past 7 days, but a 8.4% decline over 30 days, a 16.8% decline year to date, and a 20.9% decline over 1 year, while the 5 year return sits at 9.3% and the 3 year return at a 30.1% decline. Recent coverage around...
ENXTPA:CA
ENXTPA:CAConsumer Retailing

Carrefour (ENXTPA:CA) Valuation Check After Recent Share Price Pullback And Mixed Signals

Carrefour share move and recent performance snapshot With no single headline event driving recent trading, Carrefour (ENXTPA:CA) has drawn attention after a 4.8% decline over the past day, set against a 5.3% gain over the past month. Over the past 3 months, the stock shows a 14.1% total return, while the past year sits at 16.3%. Year to date, performance is closer to 1.7%. This points to a different picture over shorter periods. See our latest analysis for Carrefour. At a share price of...
ENXTPA:ICAD
ENXTPA:ICADREITs

Does Icade’s Narrowed 2025 Net Loss Amid Office Headwinds Reshape The Bull Case For Icade (ENXTPA:ICAD)?

On February 17, 2026, Icade’s board approved the financial statements for the year ended December 31, 2025, alongside releasing full-year results showing sales of €346.5 million and revenue of €1.45 billion. The company cut its net loss to €123 million, with basic and diluted loss per share narrowing to €1.62, highlighting a clear improvement in bottom-line performance despite lower top-line figures. We’ll now examine how Icade’s reduced full-year net loss and ongoing office-market headwinds...
ENXTPA:VU
ENXTPA:VUElectronic

Assessing Vusion (ENXTPA:VU) Valuation After Carrefour 2030 Digital Shelf Rollout Agreement

Carrefour partnership puts Vusion’s European rollout in focus Vusion (ENXTPA:VU) is back on investors’ radar after Carrefour agreed to roll out its digital shelf labels, IoT rails, and AI shelf monitoring across all French hypermarkets and supermarkets by 2030. See our latest analysis for Vusion. The Carrefour agreement comes after a sharp 1 day share price return of 9.99% to €131.0. However, the 30 day and year to date share price returns of 9.78% and 37.32% declines indicate that momentum...
ENXTPA:KER
ENXTPA:KERLuxury

Is It Time To Reassess Kering (ENXTPA:KER) After Its Multi Year Share Price Slump

If you are wondering whether Kering is attractively priced or still carrying a premium, this article walks through what the current share price might be implying about its value. The stock closed at €272.90, with returns of a 5.2% decline over 7 days, a 5.5% decline over 30 days, a 10.4% decline year to date, a 2.1% gain over 1 year, a 48.8% decline over 3 years and a 40.5% decline over 5 years, which gives long term holders a mixed experience. Recent attention on Kering has centered on how...
ENXTPA:ARAMI
ENXTPA:ARAMISpecialty Retail

European Penny Stocks Worth Watching In February 2026

European markets have recently experienced volatility, with the pan-European STOXX Europe 600 Index reaching a new high but ending the week with only a slight gain. This backdrop presents an intriguing landscape for investors considering penny stocks, which are often smaller or newer companies that can offer unexpected value. Despite their vintage moniker, these stocks remain relevant and can provide compelling opportunities for those seeking to explore beyond well-known names, particularly...